GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/GI Surgery/Onlay Mesh Preferred in Ventral Hernia Repair : JAMA Surg | May 2026

Onlay Mesh Preferred in Ventral Hernia Repair : JAMA Surg | May 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated May 1, 2026

Quick Answer

Introduction: Mesh reinforcement is the standard of care for primary ventral hernia repair, yet the optimal anatomical position for mesh placement remains controversial. Common techniques include onlay, preperitoneal, retromuscular, and intraperitoneal onlay mesh (IPOM) placement.


Introduction:

Mesh reinforcement is the standard of care for primary ventral hernia repair, yet the optimal anatomical position for mesh placement remains controversial. Common techniques include onlay, preperitoneal, retromuscular, and intraperitoneal onlay mesh (IPOM) placement. While each approach has theoretical advantages, comparative real-world evidence regarding long-term recurrence and bowel obstruction remains limited. This large nationwide Danish cohort study evaluated the impact of mesh positioning on clinically relevant postoperative outcomes.

Problem Statement:

Surgeons must balance recurrence prevention against procedure-related complications when selecting mesh placement techniques. However, robust population-level data comparing recurrence and bowel obstruction risks across different mesh positions are scarce, making evidence-based selection challenging.

Summary:

This nationwide registry-based cohort study included 17,832 adults who underwent elective primary umbilical or epigastric ventral hernia repair with mesh reinforcement between 2014 and 2025. Patients were categorized according to mesh position: onlay (8,764 patients), retromuscular (1,239), preperitoneal (4,292), and IPOM (3,537). Outcomes were assessed using national healthcare databases with long-term follow-up.

Compared with onlay mesh placement, both retromuscular and IPOM techniques were associated with significantly higher risks of reoperation for hernia recurrence. Retromuscular placement increased recurrence risk by 63%, while IPOM increased risk by 38%. In contrast, preperitoneal mesh placement demonstrated recurrence outcomes comparable to onlay repair.

Bowel obstruction risk also differed substantially according to mesh location. Retromuscular placement doubled the risk of bowel obstruction, whereas IPOM was associated with more than a threefold increase compared with onlay mesh placement. Preperitoneal repair again showed no significant increase in bowel obstruction risk.

These findings challenge the traditional perception that retromuscular mesh placement consistently provides superior long-term outcomes. The authors suggest that factors such as mesh-related adhesions, tissue plane characteristics, and technical variability may contribute to the observed differences.

Clinically, the study supports onlay and preperitoneal mesh placement as favorable options for primary ventral hernia repair when considering both recurrence and bowel obstruction risks. Preperitoneal repair may be particularly attractive because it combines low recurrence rates with a low risk of bowel obstruction.

Overall, this large real-world analysis suggests that onlay and preperitoneal mesh placement provide the most favorable balance between durability and safety, whereas retromuscular and IPOM techniques may carry higher risks of recurrence and postoperative bowel obstruction requiring reoperation.

Related Q&A

Mesh Fixation and Chronic Groin Pain: BJS Open | July 2026

Introduction: Chronic postoperative inguinal pain (CPIP) remains one of the most important long-term complications after laparoscopic groin hernia repair, despite lower rates than with open surgery. Whether different mesh types and fixation methods influence the...

Collateral-Based PD Without Venous Reconstruction: Indian J Gastroenterol | July 2026

Introduction: Venous involvement is common in locally advanced pancreatic cancer and often necessitates superior mesenteric-portal vein resection with reconstruction during pancreaticoduodenectomy. However, reconstruction may not always be feasible because of extensive venous disease or unfavorable...

Robotic vs Open Pancreatoduodenectomy: BMJ | July 2026

Introduction: Pancreatoduodenectomy remains one of the most complex abdominal operations. Robotic pancreatoduodenectomy (RPD) has been proposed to improve postoperative recovery, but robust randomized evidence has been limited. The PORTAL trial compared robotic and open pancreatoduodenectomy...

Adapting Military Resilience to Modern Surgery by SOSC: An of Surgery | July 2026

Introduction: Surgery is an inherently high-stress profession, where complications, patient deaths, and difficult decisions can lead to burnout, moral injury, and mental health disorders. Inspired by the US Marine Corps' Combat and Operational Stress Control...

Vascular Resection for Pancreatic Cancer: Annals of Surgery | June 2026

Introduction: As surgical techniques and perioperative therapies have advanced, vascular resection during pancreatic cancer surgery has become increasingly common in selected patients with locally advanced disease. This study evaluated the long-term outcomes of venous and...

Drain Management After Pancreatoduodenectomy: BJS Open | June 2026

Introduction: Optimal drain management after pancreatoduodenectomy (PD) remains critical for preventing postoperative pancreatic fistula (POPF) while supporting enhanced recovery. This study proposes a dynamic, risk-adapted algorithm based on intraoperative risk and postoperative biochemical markers. Why...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer